Core Viewpoint - The company *ST Baoying announced that its stock will continue to be suspended from trading starting October 22, 2025, for a period not exceeding three trading days due to ongoing plans for a change in control by its major shareholder, Zhuhai Dahengqin Group Co., Ltd [1] Summary by Relevant Sections - **Stock Suspension** - The company's stock will remain suspended from trading starting October 22, 2025, with an expected duration of no more than three trading days [1] - **Change in Control** - The major shareholder, Zhuhai Dahengqin Group Co., Ltd, is planning a change in the company's control, which may lead to changes in the controlling shareholder and actual controller [1] - **Uncertainty and Disclosure** - Due to the ongoing planning of the related matters, there is significant uncertainty, and the company anticipates it will not be able to resume trading on October 22, 2025. During the suspension, the company will fulfill its information disclosure obligations based on the progress of the matters [1]

证券代码：002047 证券简称：*ST 宝鹰 公告编号：2025-061 深圳市宝鹰建设控股集团股份有限公司 关于筹划公司控制权变更事项进展暨继续停牌的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、公司股票自 2025 年 10 月 22 日开市起继续停牌，预计停牌时间不超过 3 个交易日。 2、公司控制权变更事项目前处于筹划阶段，尚存在重大不确定性，敬请广 大投资者注意投资风险。 一、停牌情况概述 深圳市宝鹰建设控股集团股份有限公司（以下简称"公司"）收到公司控股 股东珠海大横琴集团有限公司（以下简称"大横琴集团"）的通知，大横琴集团 正在筹划公司控制权变更事宜，该事项可能导致公司控股股东、实际控制人发生 变更。鉴于上述事项处于筹划阶段，尚存在重大不确定性，为维护公司全体股东 利益，经公司向深圳证券交易所申请，公司股票（股票代码：002047，股票简称： *ST 宝鹰）自 2025 年 10 月 20 日（星期一）开市起停牌，预计停牌时间不超过 2 个交易日。具体内容详见公司在指定信息披露媒体《证券时报》《证券日报》《上 海证券报》 ...

Core Points - *ST Baoying (002047) announced that its stock will continue to be suspended from trading starting October 22, 2025, with an expected suspension period of no more than 3 trading days [1] - The company's controlling shareholder, Zhuhai Dahengqin Group Co., Ltd., is planning a change in the company's control, which may lead to a change in the controlling shareholder and actual controller [1] - Due to the ongoing planning of related matters, there is significant uncertainty, and the company anticipates it will not be able to resume trading on October 22, 2025 [1] - During the suspension period, the company will fulfill its information disclosure obligations based on the progress of the matters [1]

Core Viewpoint - Shenzhen Baoying Construction Holding Group Co., Ltd. is planning a change in company control, which may lead to a change in the controlling shareholder and actual controller [1][2]. Group 1 - The company's stock will be suspended from trading starting October 20, 2025, with an expected suspension period of no more than two trading days [1][2]. - The control change is currently in the planning stage and carries significant uncertainty, prompting the company to remind investors to be cautious [1][2]. - The company will fulfill its information disclosure obligations according to relevant laws and regulations during the suspension period and will announce any developments regarding the control change [2].

1、公司股票于2025年10月20日开市起停牌，预计停牌时间不超过2个交易日。 2、公司控制权变更事项目前处于筹划阶段，尚存在重大不确定性，敬请广大投资者注意投资风险。 证券代码：002047 证券简称：*ST宝鹰 公告编号：2025-060 深圳市宝鹰建设控股集团股份有限公司 关于筹划公司控制权变更事项的停牌公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 特此公告。 深圳市宝鹰建设控股集团股份有限公司 董事会 2025年10月20日 深圳市宝鹰建设控股集团股份有限公司（以下简称"公司"）收到公司控股股东珠海大横琴集团有限公司 （以下简称"大横琴集团"）的通知，大横琴集团正在筹划公司控制权变更事宜，该事项可能导致公司控 股股东、实际控制人发生变更。 鉴于上述事项处于筹划阶段，尚存在重大不确定性，为维护公司全体股东利益，根据《深圳证券交易所 股票上市规则》《深圳证券交易所上市公司自律监管指引第6号一一停复牌》等相关规定，经公司向深 圳证券交易所申请，公司股票（股票代码：002047，股票简称：*ST宝鹰）自2025年10月20日（星期 一）开市 ...

Group 1 - Yonghe Co., Ltd. reported a net profit of 469 million yuan for the first three quarters, a year-on-year increase of 220.39% [1] - Jinli Permanent Magnet achieved a net profit of 515 million yuan, reflecting a year-on-year growth of 161.81% [1][2] - Sanhe Pharmaceutical Auxiliary's net profit increased by 8.28% year-on-year, reaching 133 million yuan [2] Group 2 - Jiahuan Technology experienced a net profit decline of 26.53%, totaling 55.35 million yuan [3] - Wuchan Huaneng reported a net profit decrease of 15.10%, amounting to 453 million yuan [3] - Chuan Investment Energy's net profit fell by 4.54%, totaling 4.22 billion yuan [4][5] Group 3 - Dayang Bio's net profit grew by 56.12%, reaching 80 million yuan [5] - Weili Medical reported a net profit increase of 14.94%, totaling 192 million yuan [6] - People's Tongtai's net profit decreased by 45.69%, amounting to 112 million yuan [7] Group 4 - Jiuhuan Bio received a medical device registration certificate for its NT-proBNP test kit [8] - Jincheng Pharmaceutical's subsidiary obtained a drug registration certificate for a specific injection [9] - Guangdian Yuntong's subsidiary acquired a money service operator license in Hong Kong [10] Group 5 - Dash Intelligent won a bid for a project worth 96 million yuan related to the Shijiazhuang subway [10] - Alloy Investment's net profit increased by 124.87%, reaching 7.26 million yuan [11] - Kaile Co., Ltd. reported a net profit growth of 159.14%, totaling 21.63 million yuan [12] Group 6 - Chuanjinno's net profit surged by 175.61%, reaching 304 million yuan [14] - Rijiu Optoelectronics reported a net profit increase of 36.54%, totaling 76.91 million yuan [15] - Dazhu CNC's net profit grew by 142.19%, amounting to 492 million yuan [15] Group 7 - Nairui Radar expects a net profit increase of 181% for the first three quarters [17] - Suzhou Tianmai successfully acquired land use rights for a new manufacturing project [19] - Aokai Pharmaceutical announced clinical research data for its innovative drug at a major conference [21][22] Group 8 - Jilin Aodong's subsidiary passed the consistency evaluation for a specific injection [24] - Qinxin Environment announced the resignation of a board member [25] - *ST Baoying is planning a change in control, leading to a stock suspension [26] Group 9 - Jianlang Hardware's director plans to reduce holdings by up to 500,000 shares [27] - Taihe Technology's director intends to reduce holdings by up to 606,000 shares [29] - Zhongyuan Securities announced a cash dividend of 0.008 yuan per share [31] Group 10 - Beijing-Shanghai High-Speed Railway plans to distribute a cash dividend of 0.0385 yuan per share [32] - Zhuhai Guanyu expects a net profit increase of 36.88%-55.54% for the first three quarters [34] - Shenglong Co., Ltd. reported a net loss of 72.95 million yuan for the first three quarters [36] Group 11 - Shuangyuan Technology plans to distribute a cash dividend of 0.125 yuan per share [38] - Shaanxi Guotou A reported a net profit increase of 6.6%, totaling 996 million yuan [40] - Sunshine Nuohua intends to invest 15 million yuan in a biotech company [41] Group 12 - Yangjie Technology's net profit increased by 45.51%, reaching 974 million yuan [42] - Xingwang Yuda reported a net profit growth of 260%, totaling 38.37 million yuan [43] - Tongyou Technology turned a profit with a net profit of 9.29 million yuan [44]

Core Viewpoint - *ST Baoying (002047) is undergoing a potential change in control as its major shareholder, Zhuhai Dahengqin Group Co., Ltd., is planning to alter the company's control structure, which may lead to a change in the controlling shareholder and actual controller [1] Group 1: Stock Suspension - The company has applied for a stock suspension starting from October 20, 2025, due to the uncertainty surrounding the control change, with the suspension expected to last no more than two trading days [1][4] - Prior to the suspension, *ST Baoying's stock price increased by 4.33%, reaching 2.41 yuan per share, with a total market capitalization of 3.654 billion yuan [5] Group 2: Stock Price Fluctuation - On October 16 and 17, 2025, *ST Baoying's closing price deviation exceeded 12%, indicating abnormal trading activity [7] - The Shenzhen Stock Exchange issued a regulatory letter to *ST Baoying regarding the abnormal price fluctuations and the need for compliance with trading rules [8] Group 3: Internal Control Issues - The company has been found to have deficiencies in internal controls related to project management, procurement management, and fund management, leading to inaccurate disclosures regarding related party cash donations in December 2024 [8] - The former chairman, general manager, and financial director of *ST Baoying have been held responsible for failing to fulfill their duties and for the company's violations of the Shenzhen Stock Exchange's listing rules [8][10]

停牌。 *ST宝鹰（002047）10月20日午间公告，公司收到公司控股股东珠海大横琴集团有限公司（简称"大横琴集团"）的通知，大横琴集 团正在筹划公司控制权变更事宜，该事项可能导致公司控股股东、实际控制人发生变更。 公告称，鉴于上述事项处于筹划阶段，尚存在重大不确定性，为维护公司全体股东利益，根据《深圳证券交易所股票上市规则》 《深圳证券交易所上市公司自律监管指引第6号——停复牌》等相关规定， 经公司向深圳证券交易所申请，公司股票自2025年10月 20日（星期一）开市起停牌，预计停牌时间不超过2个交易日。 值得一提的是，*ST宝鹰昨日（10月19日）晚间公告，公司2025年10月16日、2025年10月17日连续两个交易日收盘价格涨幅偏离 值累计超过12%，根据《深圳证券交易所交易规则》等有关规定，公司股票交易属于异常波动的情形。 股票停牌期间，公司将根据上述事项进展情况，严格按照有关法律法规的规定和要求履行信息披露义务。待上述事项确定后，公司 将及时发布相关公告并申请公司股票复牌。 停牌前，*ST宝鹰股价上涨4.33%，报2.41元/股，总市值36.54亿元。 转载与合作可联系证券时报小助理，微信ID： ...

Core Viewpoint - The company *ST Baoying (002047)* is undergoing a potential change in control as its major shareholder, Zhuhai Dahengqin Group Co., Ltd., is planning to alter the company's control structure [1] Group 1 - The company received a notification from its controlling shareholder regarding the planned change of control [1] - This change may result in a shift in the company's major shareholder and actual controller [1] - The company has applied for a trading suspension, effective from October 20, 2025, with an expected duration of no more than 2 trading days [1]

Core Viewpoint - The company *ST Baoying (002047.SZ) is undergoing a potential change in control as its major shareholder, Zhuhai Dahengqin Group Co., Ltd., is planning to alter the company's control structure, which may lead to a change in the controlling shareholder and actual controller [1] Summary by Sections - The company has received a notification from its major shareholder regarding the planned change in control [1] - As a result of this announcement, the company has applied for a trading suspension of its stock starting from October 20, 2025, with an expected suspension period of no more than 2 trading days [1]